查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133477

全球轉移膜市場-2022-2029

Global Transfer Membrane Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

轉移膜市場的增長受到生命科學研究領域私人和公共資金增加、靶向疾病研發活動增加以及生物製劑不斷進步的推動

預計生命科學領域的資金增加將推動市場增長

預計來自私人和公共機構的不斷增加的資金將在預測期內提振市場。過去幾年，人口統計、經濟、技術和快速技術進步等各種大趨勢推動了生命科學領域的發展。在新產品開發、新技術以及公共和私人投資者增加資金的推動下，生命科學行業正處於上升軌道。例如，在過去兩年中，北美的生命科學公司在 2020 年獲得了驚人的 700 億美元，在 2021 年從美國國立衛生研究院 (NIH) 獲得了 780 億美元的私人資本和公共資金，呈現出強勁的增長勢頭。

此外，默克集團將在 2022 年提供一系列研究資助，以激發未來最具挑戰性領域的創新研究。在藥物發現、綠色化學創新以及用於預測診斷和治療靶向的人工智能等領域，每年可獲得高達 500,000 歐元的資助，最長可達三年。增加新產品開發的資金和研究活動正在推動全球轉移膜市場。

缺乏熟練的醫療保健專業人員阻礙了市場增長

然而，當大流行來襲時，醫療保健行業面臨新的挑戰，被迫迅速適應疫情並迅速應對挑戰。另一方面，研究部門繼續強勁增長，需要熟練從事研究活動的人員。缺乏熟練的醫療保健專業人員是限制膜市場增長的原因。

COVID-19 影響分析

COVID-19 的出現對全球轉移膜市場產生了相當大的影響。 2020 年 1 月，世界衛生組織 (WHO) 國際衛生條例緊急委員會宣布冠狀病毒病 (COVID-19) 的爆發為國際公共衛生緊急事件。最近，COVID-19 大流行增加了生命科學領域的重要性，尖端創新如用於治療冠狀病毒感染的疫苗開發在實驗室取得進展。

另一方面，封閉環境對轉移膜原料的生產產生不利影響。供應鏈中斷和運輸限制減緩了全球市場。隨著情況從 COVID-19 中恢復，我們現在能夠獲得研究活動的基本要求。由於受監管的供應鍊和原材料的易得性，轉移膜市場在全球範圍內不斷增長。

您可以在全球傳輸膜市場報告中訪問大約 75 多個市場數據表、75 多個數字和 250 多個頁面（大約）。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型：市場細分
  • 按轉移方式：市場細分
  • 按檢測方法：市場細分
  • 按應用：市場細分
  • 按最終用戶：市場細分
  • 按地區：市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 生命科學領域的資金增加
      • 研究活動增加
    • 約束因素
    • 缺乏熟練的醫療保健專業人員
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 尼龍
  • 硝酸纖維素
  • 聚偏氟乙烯

第8章轉錄方法

  • 濕式/罐式傳輸
  • 半乾式電轉印
  • 乾式傳輸
  • 其他

第九章檢測方法

  • 化學發光
  • 顯色法
  • 放射性物質

第 10 章按應用程序

  • Northern印跡
  • Southern印跡
  • 蛋白質印跡
  • 蛋白質測序和氨基酸分析
  • 其他

第 11 章，最終用戶

  • 診斷機構
  • 學術和研究機構
  • 製藥和生物技術公司
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按治療類型劃分的基準

第 14 章公司簡介

  • Abcam 公司
    • 公司概況
    • 治療類型組合和描述
    • 主要亮點
    • 財務摘要
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc.
  • MACHEREY-NAGEL GmbH & Co. KG
  • General Electric Company
  • Carl Roth GmbH+Co. KG
  • Azure Biosystems, Inc.
  • ATTO Corporation
  • Bio-Rad Laboratories, Inc.
  • Advansta Inc.

第 15 章全球轉印膜市場-DataM

簡介目錄
Product Code: DMBT5854

Market Overview

Transfer Membrane Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of x% during the forecast period (2022-2029).

Transfer membranes are used in blotting techniques as part of the solid phase support upon which proteins or nucleic acids are transferred from gel matrices so that detection and analysis may be performed. After size separation by electrophoresis in agarose gel, polyacrylamide proteins or nucleic acids are stable on a solid matrix membrane, enabling the detection of specific proteins or nucleic acids using antibodies directed against the specific target.

Market Dynamics

The transfer membrane market growth is driven by the rising private and public funding in life science research, increasing research and development activities for targeted diseases and rising advancementnt in biologics

The rising funding for life sciences is expected to drive the market growth

The rising funding from private and public organizations is expected to boost the market over the forecast period. Various mega trends such as demographic, economic, and technological coupled with quick advances in technology have drive life sciences growth in the past years. The life sciences industry has on the rise due to a surge in new products development and technology, as well as an increase of funding from both public and private investors. For instance, the last two years witnessed for tremendous growth with $70 billion of private equity capital and public National Institutes of Health (NIH) funding pouring into life sciences-related companies in North America in 2020 and a record $78 billion in 2021.

In addition, in 2022, Merck group is offered a series of research grants to stimulate innovative research most challenging sectors of future importance. Grants of up to 500,000 € per year for up to 3 years are available in the areas such as drug discovery, innovations within green chemistry, AI for predictive diagnostics & therapeutic target discovery, and others. Increasing funding and research activities to develop new products drive the transfer membrane market globally.

The lack of skilled healthcare professionals will hamper the growth of the market

However, during the pandemic healthcare sector faced a new set of challenges in forcing it to rapidly adapt to the onset of the pandemic and rapidly mobilize to meet the challenge. while the research sector's continued delivery of strong growth means workers have to be skilled in research activities. Lack of skilled healthcare professionals are limits transfer membrane market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global transfer membrane market. In January 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) announced that the coronavirus disease (COVID-19) outbreak a public health emergency of internationally. More recently, the COVID-19 pandemic people the life sciences sector to a advanced level of importance with cutting-edge innovations such as to develop vaccines are ongoing in the laboratory to treat infection of coronavirus.

On the other hand, the forceful lockdowns has negatively impacted the production of raw materials for transfer membrane. The supply chain disruptions and transportation restrictions hampered the market globally. As the situation is recovering from COVID-19 the essential requirements are now accessible for research activities. Due to a regulated supply chain and easy availability of raw materials the transfer membrane market is growing worldwide.

Segment Analysis

The western blotting segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The western blotting segment is expected to boost the market over the period of the forecast. The article published in the National Library of Medicine mentioned that western blot is commonly used in research laboratories to separate and identify proteins. In this technique, a mixture of proteins is separated based on molecular weight, through gel electrophoresis. Then, these results are transferred to a membrane producing a band for each protein. This blotting technique is used for indentification of nuclic acids, detection of radioactive probe in the sample. In western blotting technique mainly nitrocellulose and polyvinylidene difluoride (PVDF) are the membranes used for blotting applications. Both membranes are microporous characteristics that bind proteins to their surface via hydrophobic interactions.

Geographical Analysis

North America region holds the largest market share of the global transfer membrane market

North America dominates the market for transfer membrane and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to technological advancement, rising funding for life science research, rising innovations in healthcare sectors and presence of market players. The key players such as Pfizer Inc. AstraZeneca, Johnson and Johnson, Merck and others. As per the 2022 Clinical trial.gov data approximately more than 500 active clinical trials are ongoing for different cancer in alone United States.

In addition, the market players are offering the different transfer membrane in the North American Market. For instance, Merck offers four different PVDF membranes including Immobilon E, Immobilon P, Immobilon PSQ and Immobilon FL each developed for different protein blotting applications. These transfer membranes are suitable for western blotting application with broad range of excitation and emission wavelengths.

Competitive Landscape

The transfer membrane market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Abcam plc., Thermo Fisher Scientific Inc., PerkinElmer Inc., MACHEREY-NAGEL GmbH & Co. KG, General Electric Company, Carl Roth GmbH + Co. KG, Azure Biosystems, Inc., ATTO Corporation., Bio-Rad Laboratories, Inc., and Advansta Inc. among others. The major players are adopting several growth strategies such as Treatment type launches, acquisitions, and collaborations, which are contributing to the growth of the transfer membrane market globally.

Thermo Fisher Scientific

Overview:

Thermo Fisher Scientific is an analytical laboratory manufacturing company established in 1956, headquartered in United States. It offers the membranes such as nylon, nitrocellulose, PVDF featuring as ease use, high binding capacity and large surface area-to-volume area ratio.

Treatment Type Portfolio:

Nitrocellulose Membranes: It is common matrix used in protein blotting due to their high protein-binding affinity, compatibility with a variety of detection methods, and the ability to immobilize proteins and glycoproteins. it may also be used for the applications such as amino acid analysis ,southern and northern blots, and dot/slot blot.

The global transfer membrane market report would provide access to approximately 75+ market data tables, 75+ figures, and in the range of 250+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Transfer Method
  • 3.3. Market Snippet By Detection Method
  • 3.4. Market snippet By Application
  • 3.5. Market snippet By End User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising funding for life science projects
      • 4.1.1.2. The increasing number of research activities
    • 4.1.2. Restraints:
    • 4.1.3. Lack of skilled healthcare professionals in the market
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Nylon*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Nitrocellulose
  • 7.4. PVDF

8. By Transfer Method

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method Segment
    • 8.1.2. Market Attractiveness Index, By Transfer Method Segment
  • 8.2. Wet or Tank Electrotransfer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Semi-dry Electrotransfer
  • 8.4. Dry Electrotransfer
  • 8.5. Others

9. By Detection Method

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 9.1.2. Market Attractiveness Index, By Detection Method
  • 9.2. Chemiluminescent*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Chromogenic
  • 9.4. Radiometric

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Northern Blotting*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Southern Blotting
  • 10.4. Western Blotting
  • 10.5. Protein Sequencing and Amino Acid Analysis
  • 10.6. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Diagnostic Laboratories*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Academic and Research Institutes
  • 11.4. Pharmaceutical and Biotechnology Companies
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Transfer Method
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Detection Method
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Treatment type Benchmarking

14. Company Profiles

  • 14.1. Abcam plc.*
    • 14.1.1. Company Overview
    • 14.1.2. Treatment type Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Thermo Fisher Scientific Inc
  • 14.3. PerkinElmer Inc.
  • 14.4. MACHEREY-NAGEL GmbH & Co. KG
  • 14.5. General Electric Company
  • 14.6. Carl Roth GmbH + Co. KG
  • 14.7. Azure Biosystems, Inc.
  • 14.8. ATTO Corporation
  • 14.9. Bio-Rad Laboratories, Inc.
  • 14.10. Advansta Inc.

LIST NOT EXHAUSTIVE

15. Global Transfer Membrane market- DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us